Briacell Therapeutics Corp (BCTX)

Briacell Therapeutics Corp (BCTX) 財務データ

損益計算書

四半期ごと

*すべての数値は百万単位です

期間終了日	2024-01-31	2023-10-31	2023-07-31	2023-04-30	2023-01-31
期間の長さ	3 か月	3 か月	3 か月	3 か月	3 か月
Revenues	-	-	-	-	-
Operating Expenses	15.60% 9.8294	8.503	-	5.677	4.4863
Depreciation and Amortization	0.03% 0.00382	0.00382	-	-	-
Operating Income/Loss	15.60% -9.8294	-8.503	-7.7058	-5.677	-4.4863
Nonoperating Income/Loss	110.28% -1.4861	14.46	5.2871	0.7816	-7.3954
Income/Loss From Continuing Operations Before Tax	290.20% -11.33	5.9589	-2.4187	-4.8954	-11.88
Income/Loss From Continuing Operations After Tax	290.20% -11.33	5.9589	-2.4187	-4.8954	-11.88
Net Income/Loss	290.20% -11.33	5.9589	-2.4187	-4.8954	-11.88
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	7.88% -0.0393	-0.0427	-	-	-
Basic Average Shares	0.00% 15.98	15.98	0.1016	15.52	15.52
Diluted Average Shares	4.16% 15.98	16.67	0.1016	15.52	15.52
Basic Earnings Per Share	286.84% -0.71	0.38	-	-	-0.77
Diluted Earnings Per Share	42.00% -0.71	-0.50	-0.15	-0.32	-0.77
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-